Panel Discussion: Next Gen Pharma Labs: Techniques, Technology and Adapting to rapid changes to Pharma Testings

Panelists in this video:
+ Dr Vinay Nayak, Independent Director, Aarti Industries (Moderator)
+ Dr Pritesh Upadhyay, Senior VP-Analytical Research, Lupin
+ Dr Shitalkumar Pathak, VP- Head Analytical Research & Development (Formulations), Glenmark Pharmaceuticals
+ Vipul Yamdagni, Vice President & Head – Quality (Generics), Jubilant Generics
+ Dr Sandhya Shenoy, Associate VP, FDC

Key Highlights:
+ As R&D professionals, we need to support the organisation by being agile and adapting rapidly to evolving circumstances and technological advancements: Dr Sandhya Shenoy, Associate VP, FDC

+ Lab procedures, techniques are becoming more efficient and effective with advancements in technology and equipment: Sundara Kalyana Balaji, Head-Analytical, Alembic Pharma

+ Hybrid Pharma Labs that can operate both physically and virtually will improve efficiency, GLP and productivity: Dr Shitalkumar Pathak, VP – Head Analytical Research & Development (Formulations), Glenmark Pharmaceuticals

+ As the Pharma sector becomes more systems-oriented, automation and digitalisation is driving better decisions, reducing errors, improving productivity and enabling cost optimization: Dr Pritesh Upadhyay, Senior VP – Analytical Research, Lupin

+ Covid-19 has been a tough teacher. But India Pharma Inc will turn challenges into learnings and opportunities to produce good quality and affordable medicines for India and the world: Viveka Roychowdhury, Editor, Express Pharma & Express Healthcare